XML 12 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 02, 2018
Mar. 30, 2019
Mar. 30, 2019
Mar. 28, 2020
Dec. 12, 2019
Jun. 29, 2019
Mar. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Antidilutive shares (in shares)   700,000 600,000        
Convertible Debt | 2024 Notes              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Debt, aggregate principal amount       $ 450,000,000   $ 450,000,000.0 $ 450,000,000.0
Debt, stated interest rate       0.25%     0.25%
Conversion price (in dollars per share)       $ 60.62     $ 60.62
Convertible Debt | 2026 Notes              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Debt, aggregate principal amount       $ 1,050,000,000 $ 1,050,000,000.0    
Debt, stated interest rate       0.50% 0.50%    
Conversion price (in dollars per share)       $ 99.29 $ 99.29    
Common Stock              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Shares issued upon conversion of series a preferred stock (in shares) 1,500,000            
Viavi | Amada | Convertible Series A Preferred Stock              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Number of shares sold (in shares) 35,805